Trial intelligence / Profile preview

Ondansetron + Lidocaine for Postoperative Pain in Lower Abdominal Cancer Surgery

NCT07706348Phase 2Recruiting

Sponsor
Assiut University
Start
Jun 2026
Primary completion
Jul 2027
Countries
1
01

Overview

Phase 2, randomised trial of ondansetron in acute postoperative pain (2 arms), sponsored by Assiut University. Primary endpoint: Total Morphine Consumption at 24 hours. Started Jun 2026; status: recruiting.

02

Drugs

ondansetron
03

Conditions

acute postoperative pain

Beyond the preview

Go deeper on NCT07706348.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07706348.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call